Literature DB >> 22959615

New-found fundamentals of bacterial persistence.

Cyrielle I Kint1, Natalie Verstraeten, Maarten Fauvart, Jan Michiels.   

Abstract

Persister cells display tolerance to high doses of bactericidal antibiotics and typically comprise a small fraction of a bacterial population. Recently, evidence was provided for a causal link between therapy failure and the presence of persister cells in chronic infections, underscoring the need for research on bacterial persistence. A series of recent breakthroughs have shed light on the multiplicity of persister genes, the contribution of gene expression noise to persister formation, the importance of active responses to antibiotic tolerance and heterogeneity among persister cells. Moreover, the development of in vivo model systems has highlighted the clinical relevance of persistence. This review discusses these recent advances and how this knowledge fundamentally changes the way in which we will perceive the problem of antibiotic tolerance in years to come.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22959615     DOI: 10.1016/j.tim.2012.08.009

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  52 in total

1.  Identification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa.

Authors:  Veerle Liebens; Valerie Defraine; Wouter Knapen; Toon Swings; Serge Beullens; Romu Corbau; Arnaud Marchand; Patrick Chaltin; Maarten Fauvart; Jan Michiels
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  The formation of Streptococcus mutans persisters induced by the quorum-sensing peptide pheromone is affected by the LexA regulator.

Authors:  Vincent Leung; Dragana Ajdic; Stephanie Koyanagi; Céline M Lévesque
Journal:  J Bacteriol       Date:  2015-01-12       Impact factor: 3.490

3.  Arrested protein synthesis increases persister-like cell formation.

Authors:  Brian W Kwan; John A Valenta; Michael J Benedik; Thomas K Wood
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

4.  Dormancy is not necessary or sufficient for bacterial persistence.

Authors:  Mehmet A Orman; Mark P Brynildsen
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

Review 5.  Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?

Authors:  Emir Hodzic
Journal:  Bosn J Basic Med Sci       Date:  2015-07-08       Impact factor: 3.363

Review 6.  Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.

Authors:  David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

7.  Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence.

Authors:  Bram Van den Bergh; Joran E Michiels; Tom Wenseleers; Etthel M Windels; Pieterjan Vanden Boer; Donaat Kestemont; Luc De Meester; Kevin J Verstrepen; Natalie Verstraeten; Maarten Fauvart; Jan Michiels
Journal:  Nat Microbiol       Date:  2016-03-07       Impact factor: 17.745

8.  Doc toxin is a kinase that inactivates elongation factor Tu.

Authors:  Jonathan W Cruz; Francesca P Rothenbacher; Tatsuya Maehigashi; William S Lane; Christine M Dunham; Nancy A Woychik
Journal:  J Biol Chem       Date:  2014-01-21       Impact factor: 5.157

9.  Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.

Authors:  Lee W Goneau; Nigel S Yeoh; Kyle W MacDonald; Peter A Cadieux; Jeremy P Burton; Hassan Razvi; Gregor Reid
Journal:  Antimicrob Agents Chemother       Date:  2014-01-21       Impact factor: 5.191

10.  Investigating the Effects of Osmolytes and Environmental pH on Bacterial Persisters.

Authors:  Prashant Karki; Sayed Golam Mohiuddin; Pouria Kavousi; Mehmet A Orman
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.